SMLR - NASDAQ

Semler Scientific, Inc.

SMLR·NASDAQ

$20.33

+0.0000%

HealthcareMedical - Devices

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$310.75M

EPS5.6600

P/E Ratio9.54

Earnings Date02/16/2026

239.83M

Assets

207%

3Y+373.0%

5Y+1211.0%

10Y+7689.0%

9.08M

Total Liabilities

45%

3Y+77.0%

5Y+74.0%

10Y+119.0%

230.75M

Total Equity

221%

3Y+407.0%

5Y+1665.0%

10Y-21625.0%

Semler Scientific, Inc. Funding & Solvency Profile

SMLR · NASDAQ

Current Assets

Cash & Cash Equivalents8.82M

Net Receivables4.38M

Inventory358.00K

Other Current Assets3.03M

Total Current Assets23 M

Non-Current Assets

Property, Plant & Equipment1.91M

Goodwill & Intangible Assets214.63M

Long-Term Investments512.00K

Other Non-Current Assets85.00K

Total Non-Current Assets3 M

Total Assets

239.83M

Financial Health Analysis

Current Ratio

3.59x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.04x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

16 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

9% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Semler Scientific, Inc. Balance Sheet

SMLR • NASDAQ

Semler Scientific, Inc. Balance Sheet	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	8.8M	57.2M	23M	37.3M	22.1M	7.7M	3.3M	1.5M	622K	405K	6.3M	734K	731K	28K
Short-Term Investments	6.1M	0.0	20.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	14.9M	57.2M	43.1M	37.3M	22.1M	7.7M	3.3M	1.5M	622K	405K	6.3M	734K	731K	28K
Net Receivables	4.4M	6.1M	3.9M	3.6M	2.8M	3.5M	2.8M	1.3M	877K	1.3M	355K	228K	75K	21K
Accounts Receivables	4.4M	6.1M	3.9M	3.6M	2.8M	3.5M	2.8M	1.3M	877K	1.3M	355K	228K	75K	21K
Inventory	358K	445K	469K	550K	340K	0.0	-2.8M	-1.3M	-877K	-1.3M	-355K	0.0	0.0	0.0
Prepaids	0.0	0.0	1.5M	4M	1.4M	216K	153K	111K	93K	69K	135K	47K	21K	5K
Other Current Assets	3M	2.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1M	0.0	0.0	0.0
Total Current Assets	22.7M	65.9M	48.9M	45.5M	26.6M	11.4M	6.2M	2.9M	1.6M	1.8M	6.7M	1M	827K	54K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.9M	3M	3.1M	2M	2.2M	2.3M	1.5M	1.3M	1.5M	1.3M	682K	513K	359K	242K
Intangible Assets	214.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	214.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	512K	5.9M	5.5M	821K	3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	3M	2.3M	1.9M	2.4M	4.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	85K	270K	2.8M	332K	418K	15K	15K	15K	15K	0.0	72K	202K	290K	378K
Total Non-Current Assets	217.1M	12.1M	13.8M	5.1M	8M	6.8M	1.5M	1.4M	1.5M	1.3M	754K	715K	649K	620K
Total Assets	239.8M	78.1M	62.7M	50.7M	34.6M	18.3M	7.7M	4.2M	3.1M	3.1M	7.5M	1.7M	1.5M	674K
LIABILITIES
CURRENT LIABILITIES
Total Payables	1M	2.4M	2.8M	1.6M	1.5M	404K	280K	488K	450K	839K	89K	255K	86K	119K
Accounts Payable	140K	402K	835K	443K	677K	338K	280K	488K	450K	839K	89K	255K	86K	119K
Other Payables	909K	2M	1.9M	1.2M	861K	66K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	521K	503K	358K	1.8M	413K	2.8M	2.4M	2.3M	1.5M	1.2M	721K	264K	109K	146K
Short Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	81K	0.0	2M	60K	60K	60K
Capital Lease Obligations (Current)	70K	90K	85K	80K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47K	43K	39K
Tax Payables	909K	2M	1.9M	1.2M	861K	66K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	774K	1.1M	1.2M	921K	963K	955K	435K	531K	513K	952K	612K	366K	64K	25K
Other Current Liabilities	3.9M	2.1M	2.5M	523K	1.6M	1M	355K	591K	704K	1.1M	642K	864K	817K	381K
Total Current Liabilities	6.3M	6.2M	6.9M	4.9M	4.5M	5.2M	3.5M	5.1M	3.2M	4.1M	4.1M	1.9M	1.2M	770K
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7M	2.5M	0.0	0.0	98K	158K	218K
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43K	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	2.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	332K	7K	11K	13K	230K	43K	0.0	0.0	3.6M	0.0
Total Non-Current Liabilities	2.8M	70K	160K	245K	332K	7K	11K	1.7M	2.8M	43K	0.0	163K	3.9M	373K
Capital Lease Obligations	70K	160K	245K	325K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112K	155K	194K
Total Liabilities	9.1M	6.3M	7M	5.1M	4.8M	5.2M	3.5M	6.8M	6M	4.2M	4.1M	2M	5.1M	1.1M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7M	690K	0.0
Common Stock	9K	7K	7K	7K	7K	7K	6K	6K	5K	5K	5K	3K	1K	1K
Additional Paid-In Capital	130M	12M	16.4M	20.6M	22.1M	19.4M	25.6M	23.8M	22M	21.3M	17.3M	2.3M	2.9M	3.9M
Retained Earnings	100.7M	59.8M	39.2M	24.9M	7.7M	-6.3M	-21.4M	-26.4M	-24.9M	-22.4M	-13.9M	-9.4M	-7.1M	-4.4M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	-234K	-829K	-656K	-495K	-283K	-176K	-93K	-24K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	495K	0.0	0.0	3.7M	0.0
Total Stockholders' Equity	230.8M	71.8M	55.7M	45.5M	29.8M	13.1M	4.2M	-2.6M	-2.9M	-1.1M	3.4M	-295K	-3.6M	-469K
Total Equity	230.8M	71.8M	55.7M	45.5M	29.8M	13.1M	4.2M	-2.6M	-2.9M	-1.1M	3.4M	-295K	-3.6M	-469K
SUMMARY
Total Liabilities & Equity	239.8M	78.1M	62.7M	50.7M	34.6M	18.3M	7.7M	4.2M	3.1M	3.1M	7.5M	1.7M	1.5M	674K
Total Investments	6.6M	5.9M	25.6M	821K	3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	70K	160K	245K	325K	0.0	0.0	0.0	2.9M	2.6M	0.0	2M	270K	373K	472K
Net Debt	-8.7M	-57M	-22.8M	-37M	-22.1M	-7.7M	-3.3M	1.5M	2M	-405K	-4.3M	-464K	-358K	444K
Shares Outstanding	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121	14,799,121

SEC Filings

SMLR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	January 16, 2026	January 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 13, 2026	January 13, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 12, 2025	December 11, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 14, 2025	November 14, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 12, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 12, 2025	November 12, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 10, 2025	November 10, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 17, 2025	October 16, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 03, 2025	October 03, 2025	2025	View Filing

Showing 1 to 10 of 211 filings

Related Guides

Blog Categories

Continue your SMLR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.